BioSpace News Archive

Health plan expedites access to care and provides additional support to its Medicare members

Bioscience Association Manitoba (BAM) extends a thank you to the frontline workers across the province to acknowledge their efforts during this time.

Fewer people than previously reported suffer from stroke as a result of COVID-19, a new analysis finds.

M2 Health Media, an Austin, Texas-based health and medical education delivery company, has acquired Nexus Oncology and renamed itself Nexus Health Media.

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has commenced an underwritten public offering of $75,000,000 of shares of its common stock. Flexion also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. All of the shares in the offering will be sold by Flexion.

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology today provided a company update and announced first quarter 2020 financial results

New York-based biotech company, Spectral Analytics (“Spectral”), which is working with the FDA to seek approval to initiate patient trials for a potential treatment for COVID-19.

ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today reported financial results for the quarter ended March 31, 2020.

Cabotegravir (CAB LA), administered by injection every two months, was shown to be 69% more effective than daily pills in preventing HIV acquisition

Boston Scientific Corporation (NYSE: BSX) announced that it has commenced concurrent offerings of $750.0 million of shares of its common stock (“Common Stock”) and $750.0 million of shares of its Series A Mandatory Convertible Preferred Stock